| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.09. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.09. | MANGOCEUTICALS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 04.08. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| MANGOCEUTICALS Aktie jetzt für 0€ handeln | |||||
| 10.07. | Mangoceuticals emittiert 6 % konvertierbare Vorzugsaktien der Serie B | 1 | Investing.com Deutsch | ||
| 03.07. | Mangoceuticals-Präsident Tony Isaac tritt von Vorstands- und Führungsposition zurück | 2 | Investing.com Deutsch | ||
| 03.07. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.06. | Mangoceuticals files $150M mixed securities shelf | 1 | Seeking Alpha | ||
| 10.06. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.05. | Mangoceuticals files to sell 4.46M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
| 30.05. | MANGOCEUTICALS, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 27.05. | Mangoceuticals, Inc.: Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu | 171 | GlobeNewswire (Europe) | Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and... ► Artikel lesen | |
| 23.05. | MANGOCEUTICALS, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 15.05. | MANGOCEUTICALS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.05. | MANGOCEUTICALS, INC. - 8-K, Current Report | 5 | SEC Filings | ||
| 26.04. | ArcStone US Corp.: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into th | 1.192 | Newsfile | New York, New York and Dallas, Texas--(Newsfile Corp. - April 26, 2025) - ArcStone Securities and Investments Corp. ("ArcStone"), a cross-border financial services firm, is pleased to announce its role... ► Artikel lesen | |
| 25.04. | Mangoceuticals, Inc.: Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch ... | 362 | GlobeNewswire (Europe) | DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) ("Mangoceuticals" or "MGRX"), a company focused on developing, marketing, and selling a variety of health and wellness... ► Artikel lesen | |
| 22.04. | CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape | 395 | ACCESS Newswire | DALLAS, TX / ACCESS Newswire / April 22, 2025 / Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men's performance, health, and vitality. Its pursuit comes at a time when... ► Artikel lesen | |
| 25.03. | Mangoceuticals, Inc.: Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol in the USA and Canada | 229 | GlobeNewswire (Europe) | Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss marketplace DALLAS, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals... ► Artikel lesen | |
| 04.12.24 | Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split | 122 | GlobeNewswire (Europe) | DALLAS, TX, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness products... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SPINEWAY | 0,144 | -5,01 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| NUWELLIS, INC | 3,250 | +5,52 % | Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025 | ||
| LOGICMARK | 2,130 | 0,00 % | LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth | LOUISVILLE, Ky., Aug. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMK) (the Company), a provider of personal safety, personal emergency response systems (PERS), health communications devices... ► Artikel lesen | |
| NANOVIBRONIX | 5,800 | -1,53 % | XFRA 56R1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNANOVIBRONIX NEW... ► Artikel lesen | |
| FRESENIUS | 49,000 | +0,06 % | Fresenius zieht weiter an - Analyst hebt den Daumen | Die Aktie von Fresenius kann nach dem Rücksetzer in der vergangenen Woche zum Wochenstart erneut zulegen. Im 3-Monatsvergleich ist das Papier sogar der beste Wert im deutschen Leitindex DAX vor RWE... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,530 | +0,34 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,090 | +1,29 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,990 | +1,13 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 29,040 | +3,94 % | KAUFCHANCE!? Gerresheimer Absturz! Renk Korrektur! Nakiki Aktie auf den Bitcoin-Spuren von Strategy und Metaplanet! | Die Nakiki SE elektrisiert mehr und mehr Aktieninvestoren und die Bitcoinwelt. Auf den Spuren von Strategy will man zum ersten deutschen Bitcoin Treasury Unternehmen im regulierten Markt werden. Rund... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 45,860 | -2,88 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec auf "Outperform" mit einem Kursziel von 56,40 Euro belassen. Mit der Reifung des Gesundheitssystems... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 33,520 | +0,06 % | Jefferies hebt Kursziel für BrightSpring Health wegen starker Fundamentaldaten auf 36 US-Dollar an | ||
| OTTOBOCK | 70,00 | +1,16 % | Ottobock verdoppelt die Neuromotorik-Wette: 10 Mio. € als Cornerstone | Ottobock SE & Co. KGaA baut ihr Engagement bei ONWARD Medical N.V. aus - und bleibt größter Anteilseigner. Der NeuroTech-Spezialist sammelte am 24. Oktober 2025 im Zuge einer Kapitalerhöhung insgesamt... ► Artikel lesen | |
| UNITEDHEALTH | 312,00 | +0,10 % | Nächstes Beben: Molina Healthcare crasht - UnitedHealth schwach | Die US-Krankenversicherer kommen nicht zur Ruhe. Am Mittwochabend hat der Gesundheitsdienstleister Molina Healthcare die Anleger mit enttäuschenden Zahlen erneut verunsichert. Die Aktie brach daraufhin... ► Artikel lesen | |
| GENEDX | 128,87 | +3,08 % | 4 Analysts Assess GeneDx Holdings: What You Need To Know |